WASHINGTON, LONDON and HONG KONG, March 17, 2011 /PRNewswire/ -- SuperNova Diagnostics®, Inc., a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology Co., Ltd. ("KSB"), a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets. Financial terms of the agreement were not disclosed.
"We are delighted to announce this agreement with KSB Diagnostics, a leader in China and Asia for diagnostics," said Neil Campbell, president & CEO of SuperNova Diagnostics. "This collaborative relationship allows SuperNova and KSB to expand R&D, manufacturing and commercialisation into one of the world's largest markets."
About AmpCrystal® TechnologyAmpCrystal®, SuperNova Diagnostics' lead technology with multiple product formats, allows for minimally trained individuals (advanced CLIA-waived) to test for a wide range of protein analytes and can detect directly un-amplified DNA in humans, animals or environmental samples. AmpCrystal® is hyper-dense, energy-mediated proprietary nanocrystals that can be utilised in a wide variety of diagnostic applications and configurations. The technology platform lends itself to both forward-integration into new product formats as well as backward compatible into existing open and closed diagnostic systems.
Time-to-result has been shown in prototypes to be reduced to minutes on the spot versus the hours or days required when sending samples to a central laboratory or processing in regional satellite laboratories. With three integrated capabilities (sample collector/processor, analytical disposable, and the readout device), the technology is simpler, more robust, faster and significantly less expensive than existing POC systems.
About Shenzhen Kang Sheng Bao Bio-Technology Co. Ltd "KSB"KSB provides innovative diagnostic kits and technologies to serve the large developing market in China and is a leader in vitro diagnostic reagents, OEM manufacture and contractual R&D and through partnerships possesses products with international brand (such as drugs, medical devices, bio-products, diagnostic kits, scientific research instruments, etc.), and has business relations with more than 30 countries and regions.
For additional information, please visit www.ksbbiotech.com/en/index.html
About SuperNova Diagnostics®, Inc.SuperNova® is a development-stage diagnostics company with a proprietary platform for conducting diagnostics at the site of interest with point-of-care in human health and point-of-use for non-human health applications. A powerful proprietary nanochemistry, AmpCrystal®, can deliver novel, next generation performance for pathogens, proteins, and directly measure DNA without PCR with ultra-low sensitivity and specificity while not sacrificing a dynamic range of measurements. SuperNova can be utilized in a wide range of diagnostic formats (lateral flow, self-contained cartridges, microtitre, microarrays, closed systems, research products and OEM). SuperNova® - Putting the Laboratory in the Palm of Your Hand®.
For additional information, please visit www.supernovadiagnostics.com.Media Contacts:Tiberend Strategic Advisors, Inc.(212) 827-0020Farrell Denby, firstname.lastname@example.orgTamara Bright, email@example.com
|SOURCE SuperNova Diagnostics®, Inc.|
Copyright©2010 PR Newswire.
All rights reserved